634 related articles for article (PubMed ID: 18294824)
1. A study on maize proteins as a potential new tablet excipient.
Georget DM; Barker SA; Belton PS
Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
[TBL] [Abstract][Full Text] [Related]
2. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
3. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
Li XN; Guo HX; Heinamaki J
J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
[TBL] [Abstract][Full Text] [Related]
4. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
5. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
6. Conformation of alpha zeins in solid state by Fourier transform IR.
Forato LA; Bicudo Tde C; Colnago LA
Biopolymers; 2003; 72(6):421-6. PubMed ID: 14587064
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chitosan acetate as a binder for sustained release tablets.
Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
[TBL] [Abstract][Full Text] [Related]
8. A novel zein-based dry coating tablet design for zero-order release.
Guo HX; Shi YP
Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two dextrose-based directly compressible excipients.
Olmo IG; Ghaly ES
Drug Dev Ind Pharm; 1998 Aug; 24(8):771-8. PubMed ID: 9876525
[TBL] [Abstract][Full Text] [Related]
10. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
11. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
14. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
Thumma S; Repka MA
Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
[TBL] [Abstract][Full Text] [Related]
15. The Development of Direct Extrusion-Injection Moulded Zein Matrices as Novel Oral Controlled Drug Delivery Systems.
Bouman J; Belton P; Venema P; van der Linden E; de Vries R; Qi S
Pharm Res; 2015 Aug; 32(8):2775-86. PubMed ID: 25777612
[TBL] [Abstract][Full Text] [Related]
16. Per-oral controlled release dosage form of theophylline using soybean protein.
Machida Y; Tokumura T; Nagai T
Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
[TBL] [Abstract][Full Text] [Related]
17. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
18. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
Khairuzzaman A; Ahmed SU; Savva M; Patel NK
Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
[TBL] [Abstract][Full Text] [Related]
19. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
[TBL] [Abstract][Full Text] [Related]
20. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]